Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Provention Bio Inc
(NQ:
PRVB
)
N/A
UNCHANGED
Last Price
Updated: 4:00 PM EDT, Apr 26, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Provention Bio Inc
< Previous
1
2
3
4
5
6
Next >
Why Lincoln National Shares Are Trading Lower By 31%? Here Are 72 Stocks Moving In Thursday's Session
November 03, 2022
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) gained 64% to $50.60.
Via
Benzinga
Gold Drops Over 1%; Moderna Reports Downbeat Q3 Results
November 03, 2022
U.S. stocks traded mostly lower toward the end of trading, with the Nasdaq Composite dropping over 100 points on Thursday.
Via
Benzinga
Provention Bio: Q3 Earnings Insights
November 03, 2022
Provention Bio (NASDAQ:PRVB) reported its Q3 earnings results on Thursday, November 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Crude Oil Down Over 1%; Lincoln National Shares Plunge
November 03, 2022
U.S. stocks pared some losses midway through trading, with the Nasdaq Composite dropping around 80 points on Thursday.
Via
Benzinga
US Stocks Open Lower; Nasdaq Drops 100 Points
November 03, 2022
U.S. stocks traded lower this morning, with the Nasdaq Composite dropping around 100 points on Thursday. The Federal Reserve, on Wednesday, raised interest rates by 75 bps.
Via
Benzinga
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
October proved to be a mixed month for the Food and Drug Administration’s regulatory decisions. Two new molecular entities, or NMEs, were approved during the month, bringing the tally for the...
Via
Benzinga
These 2 Growth Stocks Have Potential Catalysts on the Way
October 12, 2022
Both drugmakers have been outperforming the market -- which may continue if they earn important regulatory approvals soon.
Via
The Motley Fool
Why Immunic Shares Jumped By Around 57%; Here Are 73 Biggest Movers From Yesterday
October 11, 2022
Gainers Applied DNA Sciences, Inc. (NASDAQ: APDN) shares climbed 71% to close at $2.12 on Monday after the company announced it has received its largest single purchase order for LinearDNA™ valued...
Via
Benzinga
Cano Health, Aehr Test Systems, Credit Suisse And Other Big Gainers From Friday
October 10, 2022
U.S. stocks closed lower with the Dow Jones dropping more than 600 points on Friday. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Why NVIDIA, Microsoft And Amazon Shares Traded Lower; Here Are 73 Biggest Movers From Friday
October 10, 2022
Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) climbed 61.4% to close at $2.63 on abnormally-high volume. The company released its October investor presentation yesterday.
Via
Benzinga
Dow Drops Over 400 Points After US Economy Adds 263,000 Jobs During September
October 07, 2022
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 400 points on Friday.
Via
Benzinga
Why Aehr Test Systems Shares Are Trading Higher By Over 19%, Here Are 51 Stocks Moving In Friday's Mid-Day Session
October 07, 2022
Gainers Innovative Eyewear, Inc. (NASDAQ: LUCY) jumped 108% to $3.3943 on abnormally-high volume. The company released its October investor presentation yesterday.
Via
Benzinga
Tilray Brands, Canopy Growth, Cronos Group And Other Big Gainers From Thursday
October 07, 2022
U.S. stocks closed lower with the Dow Jones dropping more than 300 points on Thursday. Here is the list of some big stocks recording gains in the previous session.
Via
Benzinga
Why Cyclerion Therapeutics Shares Traded Lower By Around 38%; Here Are 70 Biggest Movers From Yesterday
October 07, 2022
Gainers Green Giant Inc. (NASDAQ: GGE) jumped 161.1% to close at $1.88 after dipping 29% on Wednesday.
Via
Benzinga
Dow Dips Over 300 Points; Provention Bio Shares Spike Higher
October 06, 2022
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping more than 300 points on Thursday.
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
October 06, 2022
Gainers
Via
Benzinga
Why Revelation Biosciences Shares Are Trading Higher By 29%, Here Are 50 Stocks Moving In Thursday's Mid-Day Session
October 06, 2022
Gainers Statera Biopharma, Inc. (NASDAQ: STAB) rose 98% to $0.2777. Statera Biopharma was recently granted European patent number EP3206708 titled "Methods And Compositions For The Treatment Of...
Via
Benzinga
Why Provention Bio Shares Are Skyrocketing Today
October 06, 2022
Provention Bio Inc (NASDAQ: PRVB) shares are trading higher by 20.6% to $5.97 Thursday morning after the company announced it has entered into a co-promotion agreement with Sanofi U.S. for the launch...
Via
Benzinga
2 Stocks Jumping in Thursday's Premarket Trading
October 06, 2022
Get an early start on the events of the day.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's Pre-Market Session
October 06, 2022
Gainers Statera BioPharma (NASDAQ:STAB) stock increased by 64.8% to $0.23 during Thursday's pre-market session. The company's market cap stands at $11.5 million.
Via
Benzinga
Sanofi, Provention Bio Ink Co-Promotion Pact For Type 1 Diabetes Treatment Candidate
October 06, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 20, 2022
September 20, 2022
Upgrades
Via
Benzinga
Earnings Preview For Provention Bio
August 03, 2022
Provention Bio (NASDAQ:PRVB) is set to give its latest quarterly earnings report on Thursday, 2022-08-04. Here's what investors need to know before the announcement. Analysts estimate that Provention...
Via
Benzinga
The Daily Biotech Pulse: Pfizer Inks Pact With Africa For COVID-19 Pills, Emergent Bio & Ridgeback To Increase Access To Ebola Treatment, ADC Therapeutics & Sobi In European Pact For Lymphoma Drug
July 08, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
The Daily Biotech Pulse: FDA Wants Omicron-Targeted COVID-19 Boosters, Provention Bio Clears Hits Hurdle For Diabetes Prevention Drug, Oxford Biomedica, AstraZeneca Strike Vaccine Pact
July 01, 2022
Here's a roundup of top developments in the biotech space over the last 24 hours:
Via
Benzinga
U.S. FDA Extends Review By Three Months For Provention Bio's Type 1 Diabetes Candidate
June 30, 2022
The U.S. Food and Drug Administration (FDA) has extended its review period by three months for Provention Bio’s (NASDAQ: PRVB) Biologics License Application (BLA) for teplizumab in patients with type 1...
Via
Benzinga
Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday
July 05, 2022
Gainers Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64. Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.
Via
Benzinga
Provention Bio Earnings Conference Call Is Coming Up, Here's What You Need To Know
April 28, 2022
Provention Bio (NASDAQ:PRVB) will host a conference call at 08:00 AM ET on May 5, 2022, to discuss Q1 2022 earnings results. How to Attend Provention Bio (PRVB) Conference Call Follow this link to...
Via
Benzinga
Provention Bio's Coxsackievirus Vaccine Candidate Elicits Durable Virus-Neutralizing Antibodies At Six Months
March 28, 2022
Provention Bio Inc (NASDAQ: PRVB) announced
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
February 24, 2022
Gainers Lantheus Holdings (NASDAQ:LNTH) stock rose 33.3% to $38.46 during Thursday's regular session. The current volume of 3.4 million shares is 876.7% of Lantheus...
Via
Benzinga
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.